Psoriasis Completed Phase 1 Trials for Metoprolol (DB00264)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02772601This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic ArthritisTreatment